Current position: Home >> Scientific Research >> Research Projects

凝血酶受体-1抑制剂1.1类抗血小板重大新药Andropaxpar的临床前研究

Hits:

Affiliation of Participant(s):药学院

Leading Scientist:louhongxiang

Type of Project:应用研究

Nature of Project:纵向

Project level:National

Project Participants:changwenqiang,Han Jenny,zhanghaiting,louhongxiang,sunbin,zhaiguangxi,rendongmei,xingjie,wangxiaoning,fanpeihong,shentao,Shuqi Wang

Project Number:9A6E9BCE7CDA6082E053BE07C2CADA2D

Date of Project Approval:2019-01-01

Scheduled completion time:2020-12-31

Date of Project Completion:2020-12-31

Date of Project Initiation:2019-01-01

Project Approval Number:2019ZX09301-112

Pre One:通过上调RND1表达介导EMT抑制的天然产物发现及其抗肿瘤转移作用和机制研究

Next One:诱导细胞巨泡式死亡的异戊烯基取代类化合物的发现及作用机制